Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 214

1.

Acute Effects of Dietary Carbohydrate Restriction on Glycemia, Lipemia and Appetite Regulating Hormones in Normal-Weight to Obese Subjects.

Samkani A, Skytte MJ, Thomsen MN, Astrup A, Deacon CF, Holst JJ, Madsbad S, Rehfeld JF, Krarup T, Haugaard SB.

Nutrients. 2018 Sep 12;10(9). pii: E1285. doi: 10.3390/nu10091285.

2.

Non-insulin pharmacological therapies for treating type 1 diabetes.

Frandsen CS, Dejgaard TF, Madsbad S, Holst JJ.

Expert Opin Pharmacother. 2018 Jun;19(9):947-960. doi: 10.1080/14656566.2018.1483339. Review.

PMID:
29991320
3.

Preoperative High-Dose Methylprednisolone and Glycemic Control Early After Total Hip and Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.

Lindberg-Larsen V, Kehlet H, Bagger J, Madsbad S.

Anesth Analg. 2018 Oct;127(4):906-913. doi: 10.1213/ANE.0000000000003591.

PMID:
29944516
4.

Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status.

Carlsson ER, Grundtvig JLG, Madsbad S, Fenger M.

Front Endocrinol (Lausanne). 2018 Apr 25;9:172. doi: 10.3389/fendo.2018.00172. eCollection 2018.

5.

Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist.

Iepsen EW, Zhang J, Thomsen HS, Hansen EL, Hollensted M, Madsbad S, Hansen T, Holst JJ, Holm JC, Torekov SS.

Cell Metab. 2018 Jul 3;28(1):23-32.e3. doi: 10.1016/j.cmet.2018.05.008. Epub 2018 May 31.

PMID:
29861388
6.

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.

Holst JJ, Madsbad S, Bojsen-Møller KN, Svane MS, Jørgensen NB, Dirksen C, Martinussen C.

Surg Obes Relat Dis. 2018 May;14(5):708-714. doi: 10.1016/j.soard.2018.03.003. Epub 2018 Mar 8.

7.

A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients.

Samkani A, Skytte MJ, Kandel D, Kjaer S, Astrup A, Deacon CF, Holst JJ, Madsbad S, Rehfeld JF, Haugaard SB, Krarup T.

Br J Nutr. 2018 Apr;119(8):910-917. doi: 10.1017/S0007114518000521.

PMID:
29644957
8.

Erratum to semaglutide seems to be more effective the other GLP-1Ras.

Holst JJ, Madsbad S.

Ann Transl Med. 2018 Feb;6(3):74. doi: 10.21037/atm.2018.01.20.

9.

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery.

Li QR, Wang ZM, Wewer Albrechtsen NJ, Wang DD, Su ZD, Gao XF, Wu QQ, Zhang HP, Zhu L, Li RX, Jacobsen S, Jørgensen NB, Dirksen C, Bojsen-Møller KN, Petersen JS, Madsbad S, Clausen TR, Diderichsen B, Chen LN, Holst JJ, Zeng R, Wu JR.

EBioMedicine. 2018 Feb;28:234-240. doi: 10.1016/j.ebiom.2018.01.018. Epub 2018 Feb 2.

10.

Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.

Ranjan A, Nørgaard K, Tetzschner R, Steineck IIK, Clausen TR, Holst JJ, Madsbad S, Schmidt S.

Diabetes Care. 2018 Apr;41(4):797-806. doi: 10.2337/dc17-1458. Epub 2018 Jan 22.

PMID:
29358493
11.

Semaglutide seems to be more effective the other GLP-1Ras.

Holst JJ, Madsbad S.

Ann Transl Med. 2017 Dec;5(24):505. doi: 10.21037/atm.2017.11.10. No abstract available. Erratum in: Ann Transl Med. 2018 Feb;6(3):74.

12.

Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity.

Christensen BJ, Iepsen EW, Lundgren J, Holm L, Madsbad S, Holst JJ, Torekov SS.

Obes Facts. 2017;10(6):633-647. doi: 10.1159/000481138. Epub 2017 Dec 6.

13.

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production.

Wewer Albrechtsen NJ, Kuhre RE, Hornburg D, Jensen CZ, Hornum M, Dirksen C, Svane M, Gasbjerg LS, Jørgensen NB, Gabe MN, Balk-Møller E, Albrechtsen R, Winther-Sørensen M, Galsgaard KD, Meissner F, Jorsal T, Lund A, Vilsbøll T, Eliasen R, Bojsen-Møller KN, Idorn T, Deacon CF, Knop FK, Rosenkilde MM, Hartmann B, Feldt-Rasmussen B, Mann M, Madsbad S, Holst JJ.

Cell Rep. 2017 Nov 7;21(6):1452-1460. doi: 10.1016/j.celrep.2017.10.034.

14.

Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.

Ranjan A, Wendt SL, Schmidt S, Madsbad S, Holst JJ, Madsen H, Knudsen CB, Jørgensen JB, Nørgaard K.

Basic Clin Pharmacol Toxicol. 2018 Mar;122(3):322-330. doi: 10.1111/bcpt.12907. Epub 2017 Oct 11.

PMID:
28922582
15.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.

16.

S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass Surgery.

Lylloff L, Bathum L, Madsbad S, Grundtvig JLG, Nordgaard-Lassen I, Fenger M.

Obes Facts. 2017;10(4):386-395. doi: 10.1159/000478097. Epub 2017 Aug 23.

17.

Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.

Wendt SL, Ranjan A, Møller JK, Schmidt S, Knudsen CB, Holst JJ, Madsbad S, Madsen H, Nørgaard K, Jørgensen JB.

J Diabetes Sci Technol. 2017 Nov;11(6):1101-1111. doi: 10.1177/1932296817693254. Epub 2017 Feb 1.

18.

Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trials.

von Scholten BJ, Davies MJ, Persson F, Hansen TW, Madsbad S, Endahl L, Jepsen CH, Rossing P.

J Diabetes Complications. 2017 Jul;31(7):1164-1168. doi: 10.1016/j.jdiacomp.2017.04.003. Epub 2017 Apr 11.

PMID:
28462892
19.

A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite.

Wewer Albrechtsen NJ, Asmar A, Jensen F, Törang S, Simonsen L, Kuhre RE, Asmar M, Veedfald S, Plamboeck A, Knop FK, Vilsbøll T, Madsbad S, Nauck MA, Deacon CF, Bülow J, Holst JJ, Hartmann B.

Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E284-E291. doi: 10.1152/ajpendo.00005.2017. Epub 2017 Apr 18.

20.

Glycaemic control and weight loss with semaglutide in type 2 diabetes.

Madsbad S, Holst JJ.

Lancet Diabetes Endocrinol. 2017 May;5(5):315-317. doi: 10.1016/S2213-8587(17)30094-3. Epub 2017 Apr 3. No abstract available.

PMID:
28385658

Supplemental Content

Loading ...
Support Center